Opaleye Management’s Kyntra Bio KYNB Stock Holding History

Opaleye Management’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-5,880	Closed	-$5.1M	–	53
2021 Q1	$5.1M	Hold	5,880	–	–	0.75%	42
2020 Q4	$5.45M	Hold	5,880	–	–	0.71%	38
2020 Q3	$6.04M	Buy	5,880 +40	+0.7%	+$43K	1.18%	30
2020 Q2	$5.69M	Hold	5,840	–	–	1.15%	30
2020 Q1	$5.07M	Hold	5,840	–	–	1.34%	22
2019 Q4	$6.26M	Sell	5,840 -160	-3%	-$163K	1.23%	36
2019 Q3	$5.55M	Hold	6,000	–	–	2.01%	25
2019 Q2	$6.78M	Sell	6,000 -2,000	-25%	-$2.19M	2.07%	21
2019 Q1	$10.9M	Hold	8,000	–	–	3.01%	10
2018 Q4	$9.26M	Hold	8,000	–	–	3.45%	7
2018 Q3	$12.2M	Sell	8,000 -6,400	-44%	-$9.86M	3.09%	9
2018 Q2	$22.5M	Hold	14,400	–	–	5.83%	4
2018 Q1	$16.6M	Hold	14,400	–	–	4.76%	5
2017 Q4	$17.1M	Hold	14,400	–	–	5.46%	3
2017 Q3	$19.4M	Hold	14,400	–	–	6.85%	3
2017 Q2	$11.6M	Buy	14,400 +1,200	+9%	+$836K	4.86%	3
2017 Q1	$8.13M	Hold	13,200	–	–	4.05%	3
2016 Q4	$7.06M	Hold	13,200	–	–	4.16%	5
2016 Q3	$6.83M	Hold	13,200	–	–	3.57%	6
2016 Q2	$5.42M	Buy	13,200 +200	+2%	+$91.6K	3.62%	4
2016 Q1	$6.92M	Hold	13,000	–	–	4.31%	4
2015 Q4	$9.9M	Hold	13,000	–	–	4.14%	3
2015 Q3	$7.12M	Hold	13,000	–	–	3.51%	10
2015 Q2	$7.64M	Buy	13,000 +5,346	+70%	+$3.11M	3.04%	12
2015 Q1	$6M	Hold	7,654	–	–	2.79%	16
2014 Q4	$5.23M	Buy	+7,654	New	+$4.93M	2.64%	11

Other funds holding KYNB

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Opaleye Management's KYNB Position: Q2 2021 in Review

Opaleye Management sold out of Kyntra Bio (KYNB) in Q2 2021, closing a stake of 5,880 shares — an estimated $5.1M sold.

Opaleye Management first reported a position in KYNB in Q4 2014 and held it in 26 quarters. The position peaked at $22.5M in Q2 2018. 175 funds tracked by Wall St. Rank hold KYNB as of Q2 2021.

Opaleye Management reported no remaining Kyntra Bio position as of Q2 2021 after selling out during the quarter.
Opaleye Management sold 5,880 Kyntra Bio shares in Q2 2021, an estimated $5.1M.
Opaleye Management first reported a position in Kyntra Bio in Q4 2014 and held it in 26 quarters.
Opaleye Management's Kyntra Bio position peaked at $22.5M in Q2 2018.
175 funds tracked by Wall St. Rank held Kyntra Bio as of Q2 2021.

Based on Opaleye Management's 13F filing for Q2 2021, filed 16 Aug 2021.